U.S. Semiconductors Stock News

Coty (NYSE:COTY) has entered a partnership with OpenAI to roll out artificial intelligence tools across its global operations. The company has also released a limited edition Bridgerton inspired fragrance collection in collaboration with Netflix and Shondaland. These moves highlight Coty's push to update its technology stack while testing fresh branded product concepts in the fragrance segment. Coty comes into these announcements with a current share price of $3.43 and mixed recent...

Amcor (AMCR) has just posted Q2 2026 results with revenue of US$5.4b and net income of US$177m, equal to EPS of US$0.38, putting a fresh marker down for how the packaging group is currently earning its margins. The company has seen quarterly revenue move from US$3.2b in Q2 2025 through US$5.1b in Q4 2025 to US$5.7b in Q1 2026 and now US$5.4b, while EPS has ranged from US$0.56 in Q2 2025 to a small loss in Q4 2025 before landing at US$0.57 in Q1 2026 and US$0.38 this quarter. This sets up a...

TAL Education Group recently reported past third-quarter and nine-month 2025 results, with sales rising to US$770.17 million and US$2.21 billion respectively, alongside higher net income and earnings per share from continuing operations versus the prior year. The company also completed a share repurchase of 5,039,921 shares for US$162.4 million, modestly shrinking its share count while analyst earnings expectations have been revised higher. We’ll now look at how TAL’s strong earnings growth...

Wondering if Crown Castle is offering value at its current share price, or if it is a value trap? This article walks through what the numbers suggest without the hype. The stock last closed at US$86.11, with a 1.4% gain over the past week, a 2.6% decline over the last month, a 2.9% decline year to date, a 0.8% return over 1 year, a 29.2% decline over 3 years, and a 33.4% decline over 5 years. Recent attention on Crown Castle has been driven by ongoing interest in tower and infrastructure...

In recent days, Endava reiterated its emphasis on complex digital transformation projects while issuing conservative guidance that reflects slower revenue growth and cautious enterprise demand. This shift in tone has prompted a more reserved stance from analysts, who are reassessing the company’s risk profile and longer-term growth narrative. With conservative guidance underscoring slower revenue growth, we’ll now examine how this development reshapes Endava’s broader investment narrative...

If you are wondering whether Symbotic at around US$53.48 is offering good value or asking too much, you are not alone. The stock has seen a 22.1% decline over the last 30 days and is down 17.6% year to date, even though the 1 year return sits at 73% and the 3 year return is 195.3%. Recent headlines have focused on Symbotic's role in warehouse automation and its partnerships with major retailers. This helps explain why expectations around its long term growth story remain a key talking point...

Over the past year, Sunstone Hotel Investors has benefited from a recovering lodging market, steady dividend growth, and active portfolio reshaping through asset sales and selective acquisitions in high barrier to entry locations. Management’s emphasis on ongoing renovations and asset repositioning to enhance competitive strength, supported by stable business and leisure travel demand, is increasingly central to the company’s long-term investment story. We’ll now examine how Sunstone Hotel...

In late January 2026, Joby Aviation raised roughly US$1.20 billion through a completed US$600 million follow-on common stock offering and US$600 million of 0.75% senior subordinated unsecured convertible notes due February 15, 2032. This mix of equity and long-dated convertible debt materially boosts Joby’s funding for eVTOL certification and production while increasing dilution and capital structure complexity for shareholders. Against this backdrop, we’ll examine how Joby’s large blended...

AbCellera Biologics recently highlighted its transition from a service-focused antibody discovery platform to a clinical-stage biotech, with proprietary candidates ABCL635 and ABCL575 now in Phase 1 trials and more than 100 partnered programs contributing potential royalties. This shift toward owning drug assets, alongside a broad royalty portfolio that includes 18 clinical programs, marks a meaningful change in how AbCellera may create and capture value within biopharma. We’ll now examine...

Recent performance snapshot for Astec Industries (ASTE) Astec Industries (ASTE) has drawn fresh attention after a strong run over the past year, with the stock showing positive returns over the past month, past 3 months, and year to date. See our latest analysis for Astec Industries. The recent 7 day share price return of 14.29% and 30 day share price return of 17.73% build on a year to date share price return of 22.03%, while the 1 year total shareholder return of 63.86% contrasts with a...

Fresh guidance gives investors clearer guardrails Life Time Group Holdings (LTH) recently issued earnings guidance for the fourth quarter of 2025 and the full years 2025 and 2026, giving investors fresh revenue and profit ranges to anchor expectations. The company outlined projected Q4 2025 revenue of about $743 million to $745 million, with net income of $120 million to $123 million, alongside updated full year views that extend into 2026. See our latest analysis for Life Time Group...

If you are looking at Praxis Precision Medicines and wondering whether the recent excitement is already in the price, you are not alone. The stock closed at US$303.34, with a 9.5% gain over the last 30 days, a 5.9% return year to date, a 243.8% return over 1 year, a 366.0% return over 3 years, and a 62.0% decline over 5 years. Recent company specific news has kept Praxis in focus for investors and added context to these share price moves. Headlines around its pipeline progress, regulatory...

Wondering if JetBlue Airways at around US$5.96 is a bargain or a value trap? This article walks through what the current price really reflects. The stock has returned 18.3% over the last 7 days and 24.2% over the last 30 days, while the 1 year return is a 2.6% decline and the 5 year return is a 64.2% decline. This mix can change how investors think about both risk and potential reward. Recent coverage has focused on JetBlue's ongoing efforts to reshape its route network and cost base, as...

Why Sotera Health is Back on Investors’ Radar Sotera Health (SHC) continues to attract attention after recent share price swings, with returns over the past month, past 3 months and year giving investors fresh data points to reassess the stock. See our latest analysis for Sotera Health. Recent trading has cooled slightly, with a 30 day share price return showing a 4.7% decline after a stronger 90 day gain of 13.84%. The 1 year total shareholder return of 29.35% highlights momentum that...

Reynolds Consumer Products FY 2025 earnings snapshot Reynolds Consumer Products (REYN) has wrapped up FY 2025 with fourth quarter revenue of US$1.0 billion and basic EPS of US$0.56, alongside net income of US$118 million, putting fresh numbers behind the current US$23.91 share price. Over the past two reported fourth quarters, revenue has moved from US$1.0 billion in Q4 2024 to US$1.0 billion in Q4 2025, while basic EPS shifted from US$0.58 to US$0.56. This gives investors a clear view of how...

Cabot (CBT) opened fiscal Q1 2026 with revenue of $849 million and basic EPS of $1.39, setting a clear snapshot of its latest trading quarter for investors focused on both the top and bottom line. Over recent periods, the company has seen quarterly revenue move from $955 million in Q1 2025 to $899 million in Q4 2025 and then to $849 million in Q1 2026, while basic EPS shifted from $1.69 to $0.79 to $1.39 across those same quarters, giving a mixed picture on earnings momentum as margins...

If you are wondering whether Limbach Holdings at around US$82.48 is priced attractively or has run ahead of itself, you are not alone. The stock is up 0.9% over the past week, slightly lower by 1.9% over the last 30 days, ahead by 4.3% year to date, but still showing an 18.2% decline over the past year and a very large gain over three and five years. Recent coverage of Limbach has focused on its position within capital goods and how investors are reassessing contractors that can handle...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

AGCO Corporation ( NYSE:AGCO ) has announced that it will pay a dividend of $0.29 per share on the 16th of March...

The subdued stock price reaction suggests that Extreme Networks, Inc.'s ( NASDAQ:EXTR ) strong earnings didn't offer...

Duolingo, Inc. ( NASDAQ:DUOL ) shareholders that were waiting for something to happen have been dealt a blow with a 37...

If you are asking whether Johnson & Johnson’s current share price still offers value, you are not alone. That is exactly what this article is going to unpack for you. The stock last closed at US$234.47, with returns of 3.0% over 7 days, 14.8% over 30 days, 13.1% year to date, 56.2% over 1 year, 57.0% over 3 years, and 62.0% over 5 years. This naturally raises questions about how the recent performance lines up with underlying value. Recent news around Johnson & Johnson has focused on its...

GE HealthCare Technologies (GEHC) has wrapped up FY 2025 with fourth quarter revenue of US$5.7b and basic EPS of US$1.29, setting the tone for how the full year is shaping up. The company has seen quarterly revenue move from US$5.3b in Q4 2024 to US$5.7b in Q4 2025, while basic EPS shifted from US$1.58 to US$1.29 over the same period, with trailing twelve month EPS at US$4.57 on revenue of US$20.6b. Overall, margins sit in the context of a 10.1% trailing net profit margin, giving investors a...

In recent weeks, Kingsoft Cloud Holdings has drawn attention as analysts have increasingly revised their earnings estimates higher, reflecting stronger expectations for the company’s profitability. This broad-based upgrade in forecasts has also improved Kingsoft Cloud’s position in third-party ranking systems that emphasize earnings estimate trends, highlighting a shift in how the market assesses its outlook. Next, we’ll examine how this wave of upward earnings revisions shapes Kingsoft...